Aside from any possible anti-trust violations, who is really monitoring the health-safety of all the GMO seeds that Monsanto and other plant biotechs are uploading into the world food supply?

On top of that, it now looks like scientists are beginning to challenge the fundamental assumptions behind contemporary plant biotech. From a July 1, 2007 article in the New York Times (’A Challenge to Gene Theory, a Tougher Look at Biotech’- Denise Caruso):

“Evidence of a networked genome shatters the scientific basis for virtually every official risk assessment of today’s commercial biotech products, from genetically engineered crops to pharmaceuticals.”